LEADER 01843nam 2200445 n 450 001 996392593003316 005 20200824121702.0 035 $a(CKB)4940000000111691 035 $a(EEBO)2240946028 035 $a(UnM)99869394e 035 $a(UnM)99869394 035 $a(EXLCZ)994940000000111691 100 $a19940726d1648 uy | 101 0 $aeng 135 $aurbn||||a|bb| 200 14$aThe lawes funerall. Or, An epistle written by Lieutenant Col. John Lilburn$b[electronic resource] $eprisoner in the Tower of London, unto a friend of his, giving him a large relation of his defence, made before the judges of the Kings bench, the 8. of May 1648. against both the illegal commitments of him by the House of Lords, and the House of Commons, .. 210 $a[London $cs.n.$d1648] 215 $a29, [3] p 300 $aCaption title. 300 $aSigned at end: John Lilburne. Tower the 15. of May. 1648. 300 $aThe final page is unnumbered; the 2 preceding pages are misnumbered 31 and 23. 300 $aIn this edition, the initial "A" of the epistle is surrounded by a border made of type ornaments. 300 $aImperfect: staining. 300 $aAnnotation on Thomason copy: "15 May 1648". 300 $aReproduction of the original in the British Library. 330 $aeebo-0018 606 $aHabeas corpus$zEngland$vEarly works to 1800 606 $aFalse imprisonment$zEngland$vEarly works to 1800 615 0$aHabeas corpus 615 0$aFalse imprisonment 700 $aLilburne$b John$f1614?-1657.$01001077 801 0$bCu-RivES 801 1$bCu-RivES 801 2$bCStRLIN 801 2$bCu-RivES 801 2$bWaOLN 906 $aBOOK 912 $a996392593003316 996 $aThe lawes funerall. Or, An epistle written by Lieutenant Col. John Lilburn$92372449 997 $aUNISA LEADER 04681nam 2201453z- 450 001 9910557648103321 005 20210501 035 $a(CKB)5400000000044972 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/69291 035 $a(oapen)doab69291 035 $a(EXLCZ)995400000000044972 100 $a20202105d2020 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aKilling Cancer$eDiscovery and Selection of New Target Molecules 210 $aBasel, Switzerland$cMDPI - Multidisciplinary Digital Publishing Institute$d2020 215 $a1 online resource (302 p.) 311 08$a3-03943-440-3 311 08$a3-03943-441-1 330 $aDespite the efficiency of current cancer treatments, cancer is still a deadly disease for too many. In 2008, 7.6 million people died of cancer; with the current development, it is estimated that the annual cancer death number will grow to 13 million by 2030. There is clearly a need for not only more research but also more innovative and out of the mainstream scientific ideas to discover and develop even better cancer treatments. This book presents the collective works published in the recent Special Issue entitled "Killing Cancer: Discovery and Selection of New Target Molecules". These articles comprise a selection of studies, ideas, and opinions that aim to facilitate knowledge, thoughts, and discussion about which biological and molecular mechanisms in cancer we should target and how we should target them. 517 $aKilling Cancer 606 $aBiology, life sciences$2bicssc 606 $aResearch & information: general$2bicssc 610 $a3D growth 610 $aABCG2 610 $aAF1Q 610 $aanoikis 610 $aATP-binding cassette transporter 610 $aATP6V0a3 610 $aATR pathway 610 $aautophagy 610 $aBRCA1 610 $aBRCA2 610 $abreast cancer resistance protein (BCRP) 610 $abreast cancer stem cells 610 $aC2 domain 610 $acancer 610 $acancer metabolism 610 $acancer therapy 610 $aCD domain 610 $achondroitin sulfate 610 $acolorectal cancer 610 $adexamethasone 610 $adisulfiram 610 $aDNA damage 610 $adrug efflux pumps 610 $adysferlin 610 $aEMT 610 $aepithelial-mesenchymal transition 610 $aERK1 610 $aERK2 610 $aesophageal cancer 610 $aferlin 610 $aglucocorticoids 610 $aIL-8 610 $aimmunotherapy 610 $ainflammation 610 $ainvasion 610 $akinase inhibitors 610 $alysosome 610 $alysosome-mediated invasion 610 $amammosphere 610 $aMAPK kinase 610 $amatrix degradation 610 $ametabolism 610 $amicrogravity 610 $amicrosatellite instability 610 $amigration 610 $aMLLT11 610 $amTOR in immunotherapy 610 $amTOR inhibitors 610 $amTOR signaling 610 $amTORC1 610 $amTORC2 610 $amultidrug resistance in cancer 610 $amyoferlin 610 $aMZF1 610 $an/a 610 $aNF-?B 610 $aNPL4 610 $anuclear factor kappa-light-chain-enhancer of activated B-cells (NF-?B) 610 $anutrient metabolism 610 $aoncofetal chondroitin sulfate 610 $aotoferlin 610 $aPAK4 610 $aPDAC 610 $apediatric cancer 610 $apH-regulation 610 $aphosphorylation 610 $aplasma membrane 610 $aprognosis 610 $aproliferation 610 $apyrazolo-pyrimidine derivative 610 $arapalogs 610 $areplication stress 610 $aRolled 610 $aSCH772984 610 $aSCO-201 610 $asevenmaker 610 $asolid tumors 610 $aspace environment 610 $aSTAT 610 $asulconazole 610 $aSUMOylation 610 $atarget 610 $atargeted cancer therapy 610 $aTCIRG1 610 $athyroid cancer 610 $atranscription factor 610 $aVAR2 610 $aVRT-11E 610 $aWNT 610 $azinc finger 615 7$aBiology, life sciences 615 7$aResearch & information: general 700 $aKallunki$b Tuula$4edt$01300030 702 $aKallunki$b Tuula$4oth 906 $aBOOK 912 $a9910557648103321 996 $aKilling Cancer$93025349 997 $aUNINA